Athira Pharma Inc. (ATHA)
0.53
-0.00 (-0.21%)
At close: Jan 14, 2025, 3:59 PM
0.53
-0.09%
After-hours Jan 14, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 969.00K | 1.05M | 479.00K | 2.00M | n/a | n/a |
| Gross Profit | -969.00K | -1.05M | -479.00K | -2.00M | n/a | n/a |
| Operating Income | -125.47M | -104.02M | -64.02M | -20.00M | -5.45M | -5.01M |
| Interest Income | 7.64M | 3.22M | 337.00K | 124.00K | 51.00K | 85.00K |
| Pretax Income | -117.67M | -95.64M | -54.85M | -19.95M | -5.16M | -5.10M |
| Net Income | -117.67M | -87.26M | -54.37M | -18.63M | -4.70M | -5.10M |
| Selling & General & Admin | 33.30M | 32.55M | 21.23M | 6.71M | 1.66M | 1.42M |
| Research & Development | 92.82M | 61.46M | 42.79M | 13.29M | 3.79M | 3.59M |
| Other Expenses | -1.63M | -5.16M | -8.84M | -1.32M | -754.00K | -164.00K |
| Operating Expenses | 125.47M | 88.86M | 55.19M | 18.67M | 4.70M | 5.01M |
| Interest Expense | n/a | 24.32M | 3.00K | 367.00K | 346.00K | 9.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 125.47M | 88.86M | 55.19M | 18.67M | 4.70M | 5.01M |
| Income Tax | n/a | -8.38M | -479.00K | -1.32M | -459.00K | -76.00K |
| Shares Outstanding (Basic) | 38.02M | 37.73M | 36.92M | 32.49M | 32.62M | 6.19M |
| Shares Outstanding (Diluted) | 38.02M | 37.73M | 36.92M | 32.49M | 32.62M | 6.19M |
| EPS (Basic) | -3.1 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| EPS (Diluted) | -3.09 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| EBITDA | -116.70M | -94.59M | -54.37M | -19.01M | -4.82M | -79.00K |
| Depreciation & Amortization | 969.00K | 1.05M | 479.00K | 2.00M | 2.00K | 5.01M |